- Home
- BKYI vs ENVB Comparison
BKYI vs ENVB Comparison
Compare BKYI & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- ENVB
- Stock Information
- Founded
- BKYI 1993
- ENVB 1994
- Country
- BKYI United States
- ENVB United States
- Employees
- BKYI N/A
- ENVB N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- ENVB Health Care
- Exchange
- BKYI Nasdaq
- ENVB Nasdaq
- Market Cap
- BKYI 2.7M
- ENVB 3.2M
- IPO Year
- BKYI 1997
- ENVB N/A
- Fundamental
- Price
- BKYI $0.79
- ENVB $1.28
- Analyst Decision
- BKYI
- ENVB Strong Buy
- Analyst Count
- BKYI 0
- ENVB 1
- Target Price
- BKYI N/A
- ENVB $10.00
- AVG Volume (30 Days)
- BKYI 234.7K
- ENVB 42.6K
- Earning Date
- BKYI 06-13-2025
- ENVB 05-19-2025
- Dividend Yield
- BKYI N/A
- ENVB N/A
- EPS Growth
- BKYI N/A
- ENVB N/A
- EPS
- BKYI N/A
- ENVB N/A
- Revenue
- BKYI $6,929,571.00
- ENVB N/A
- Revenue This Year
- BKYI $25.12
- ENVB N/A
- Revenue Next Year
- BKYI N/A
- ENVB N/A
- P/E Ratio
- BKYI N/A
- ENVB N/A
- Revenue Growth
- BKYI N/A
- ENVB N/A
- 52 Week Low
- BKYI $0.52
- ENVB $1.01
- 52 Week High
- BKYI $3.68
- ENVB $222.75
- Technical
- Relative Strength Index (RSI)
- BKYI 48.49
- ENVB 31.74
- Support Level
- BKYI $0.74
- ENVB $1.23
- Resistance Level
- BKYI $0.96
- ENVB $1.40
- Average True Range (ATR)
- BKYI 0.08
- ENVB 0.09
- MACD
- BKYI 0.01
- ENVB 0.15
- Stochastic Oscillator
- BKYI 41.38
- ENVB 48.15
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.